Elevated pancreatic glucagon in moderately obese patients: relationship of fatty liver and hypertriglyceridemia.
To elucidate if the presence of fatty liver and hypertriglyceridemia (HTG) influences pancreatic A-cell function in obesity, basal and arginine-stimulated glucagon (IRG) secretions were studied in 7 normal subjects and in 28 moderately obese patients (OB) with normal glucose tolerance. The patients were divided into 4 groups, based on the presence of fatty liver and/or HTG. BMI was similar in all four obese groups. Basal IRG, as well as the sum of secretory response to arginine, namely sigma IRG values, were significantly (p less than 0.01) higher in the OB subgroup having both fatty liver and HTG than in the other three groups; these values were similar in subgroups of OB without fatty liver, and showed no significant difference from the normals. Basal and sigma IRG values in all OB correlated well with the degree of fatty liver and HTG, demonstrating that by stepwise analysis the effects of fatty liver and HTG were independent for basal and sigma IRG values. These results suggest that the combination of fatty liver and HTG may serve as a good predictor of hyperglucagonemia in simple obesity, and, hence, metabolic heterogeneity among obese patients should be considered in evaluating A-cell function.
Inokuchi
T
T
Second Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
Kameyama
H
H
Orita
M
M
Kasai
T
T
Isogai
S
S
D000328:Adult; D001120:Arginine / Q000494:pharmacology; D005234:Fatty Liver / Q000150:complications*; D005934:Glucagon / Q000378:metabolism*; D006801:Humans; D015228:Hypertriglyceridemia / Q000150:complications*; D008875:Middle Aged; D009765:Obesity / Q000378:metabolism*; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*
D005934:Glucagon; D001120:Arginine